PRINT ALL
Dr. Maguire was trained in organic and medicinal chemistry and has had experience in key management roles during his 15 years in the pharmaceutical and biotechnology industries. Dr. Maguire began his career at RPR (now Sanofi-Aventis) and has established an outstanding track record in building up medicinal chemistry groups and infrastructure acquired during his tenure in biotech at Millennium Pharmaceuticals and Helios Pharmaceuticals. He has worked on multiple therapeutic targets and chemical classes that include adenosine agonists, tyrosine kinase inhibitors, MMP inhibitors, cholesterol biosynthesis inhibitors, MC4 antagonists, MCH antagonists and sigma agonists. Most recently, he led a medicinal chemistry team on an antitussive project at UCB Research. Dr. Maguire received his Ph.D. in Organic Chemistry from Boston College in 1988 and subsequently completed a 2-year postdoctoral fellowship at the University of California, Berkeley.